

BioCentury This Week
Ep. 394 - Security concerns in U.S., China reshaping biotech
Oct 27, 2026
33:40
S7 · E394
-(0)
About this episode
Proposed U.S. Treasury rules implementing the COINS Act would bar U.S. equity investments, joint ventures and co-development deals with China biotechs, potentially ensnaring Asia-to-West NewCos while leaving licensing intact. On the latest BioCentury This Week podcast, BioCentury’s analysts assess the rule’s implications for cross-border dealmaking, the competitive opening it may create for European companies, and China’s narrower-than-feared draft export controls on platform technologies. Th...
Comments
Rate this episode
Episode Details
- Author
- BioCentury
- Show Type
- full
- Audio Format
- audio/mpeg